Old-hat in­vestors Al­ta Part­ners snag $275M for their newest next-gen fund, more than dou­ble the first it­er­a­tion from 2018

Al­ta Part­ners has seen it all over the course of more than 20 years in biotech in­vest­ing, but that doesn’t mean they aren’t still look­ing to make a splash. Now, the part­ners are prop­ping up a new $275 mil­lion fund to reach for the cut­ting edge of the field — more than dou­ble the size of the team’s ini­tial next-gen fund closed just three years ago.

The San Fran­cis­co and Den­ver-based VC firm ini­tial­ly set a $225 mil­lion cap for NextGen Fund III, man­ag­ing di­rec­tor Pe­ter Hud­son told End­points News. 

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER